Sandoz S.R.L.
Sandoz S.R.L., a prominent player in the pharmaceutical industry, is headquartered in Romania (RO) and operates extensively across various regions. Founded in 2003, the company has established itself as a leader in the development and distribution of generic medicines and biosimilars, focusing on high-quality, affordable healthcare solutions. Sandoz S.R.L. is renowned for its diverse portfolio, which includes a wide range of therapeutic areas such as oncology, cardiovascular health, and infectious diseases. The company’s commitment to innovation and sustainability sets it apart in a competitive market, enabling it to meet the evolving needs of patients and healthcare providers alike. With a strong market position, Sandoz S.R.L. has achieved significant milestones, including numerous product launches and partnerships that enhance its reputation as a trusted provider of essential medications.
DitchCarbon Score
How does Sandoz S.R.L.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sandoz S.R.L.'s score of 62 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sandoz S.R.L., headquartered in Romania, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Sandoz Group AG, which influences its climate commitments and performance metrics. While Sandoz S.R.L. has not outlined specific reduction targets or achievements, it is important to note that its climate initiatives and targets are cascaded from Sandoz Group AG. This includes adherence to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which are critical frameworks for measuring and managing corporate climate impact. As a subsidiary, Sandoz S.R.L. aligns with the broader sustainability goals set by Sandoz Group AG, which may include commitments to reduce greenhouse gas emissions across various scopes. However, specific details regarding these commitments or numerical targets have not been disclosed at this level. In summary, while Sandoz S.R.L. does not provide specific emissions data or reduction targets, it operates under the climate strategies established by its parent company, Sandoz Group AG, reflecting a commitment to addressing climate change within the pharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 75,620,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 158,430,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sandoz S.R.L. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
